Acutus Medical, Inc.
AFIB
$0.0538
$0.011828.10%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 27.60% | 13.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.60% | 13.85% | |||
| Cost of Revenue | 9.49% | 22.30% | |||
| Gross Profit | 208.45% | -1,043.33% | |||
| SG&A Expenses | 4.18% | -33.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.72% | -4.25% | |||
| Operating Income | 24.22% | 23.73% | |||
| Income Before Tax | -125.41% | 82.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -125.41% | 82.38% | |||
| Earnings from Discontinued Operations | -767.93% | -226.90% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -513.46% | 43.58% | |||
| EBIT | 24.22% | 23.73% | |||
| EBITDA | 24.84% | 24.05% | |||
| EPS Basic | -511.04% | 43.59% | |||
| Normalized Basic EPS | -0.44% | 33.43% | |||
| EPS Diluted | -511.04% | 43.59% | |||
| Normalized Diluted EPS | -0.44% | 33.43% | |||
| Average Basic Shares Outstanding | 0.26% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.26% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
